TABLE 2.
Characteristics among pre-LT participants among women versus not women
| Women n=354 (41%) | Not women n=502 (59%) | p | |
|---|---|---|---|
| Self-Perceived assessment* | 2 (2–3) | 2 (1–3) | 0.06 |
| Clinician-perceived assessment* | 3 (2–3) | 2 (1–3) | 0.03 |
| Age, y* | 58 (51–63) | 56 (48–63) | 0.24 |
| Race | 0.39 | ||
| White non-Hispanic | 201 (57) | 313 (63) | |
| White Hispanic | 110 (31) | 127 (25) | |
| Black | 14 (4) | 16 (3) | |
| Asian | 26 (7) | 41 (8) | |
| Other | 3 (0.9) | 4 (0.8) | |
| BMI*, kg/m2 | 27.7 (24.0–32.7) | 28.3 (25.2–32.7) | 0.18 |
| Work (yes/no) | 58 (16) | 110 (22) | 0.04 |
| Marital Status (Married) | 187 (62) | 293 (70) | 0.02 |
| Income (<$100,000) | 77 (26) | 104 (26) | 0.98 |
| Modified Charlson Comorbidity Index | 0.04 | ||
| 0 | 208 (65) | 259 (58) | |
| 1 | 63 (20) | 84 (10) | |
| >1 | 51 (16) | 104 (23) | |
| Frailty | 94 (27) | 120 (24) | 0.38 |
| Median Liver Frailty Index* | 3.9 (3.5–4.5) | 3.8 (3.3–4.4) | 0.04 |
| Etiology | <0.001 | ||
| Alcohol | 62 (18) | 156 (31) | |
| HCV | 95 (27) | 166 (33) | |
| NAFLD | 72 (20) | 66 (13) | |
| Autoimmune | 86 (24) | 43 (9) | |
| Other | 39 (11) | 70 (14) | |
| MELD-Na* | 16 (13–19) | 16 (13–19) | 0.69 |
| Dialysis | 16 (5) | 21 (4) | 0.81 |
| HE History | 245 (70) | 327 (68) | 0.43 |
| Ascites History | 0.23 | ||
| None | 89 (26) | 112 (23) | |
| Yes | 187 (54) | 246 (51) | |
| Yes (Refractory) | 72 (21) | 124 (73) |
*
median (IQR).
Abbreviations: HCV, hepatitis C Virus; HE, hepatic encephalopathy; NAFLD; non-alcoholic fatty liver disease.